|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K 39/395 | (2013.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61P 29/00 | (2006.01) | ||
| C07K2317/33 | (2013.01) | ||
| A61P 37/06 | (2006.01) | ||
| C07K2317/76 | (2013.01) | ||
| C07K2317/92 | (2013.01) | ||
| C07K 16/2866 | (2013.01) | ||
| A61P 37/06 | (2018.01) | ||
| A61P 29/00 | (2018.01) |
| (11) | Patento numeris | 3283110 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16780800.5 |
| Europos patento paraiškos padavimo data | 2016-04-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-02-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-04-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/027676 |
| Data | 2016-04-15 |
| (87) | Numeris | WO 2016/168542 |
| Data | 2016-10-20 |
| (30) | Numeris | Data | Šalis |
| 201562147824 P | 2015-04-15 | US |
| (72) |
BOWERS, Peter , US
MCKNIGHT, Andrew John , US
KING, David J. , US
LONDEI, Marco , US
|
| (73) |
AnaptysBio, Inc. ,
10770 Wateridge Circle, Suite 210, San Diego, CA 92121,
US
|
| (54) | ANTIBODIES DIRECTED AGAINST INTERLEUKIN 36 RECEPTOR (IL-36R) |
| ANTIBODIES DIRECTED AGAINST INTERLEUKIN 36 RECEPTOR (IL-36R) |